Birgit Hirschmugl1,2, Sarah Crozier3, Nina Matthews3, Eva Kitzinger1, Ingeborg Klymiuk4, Hazel M Inskip3,5, Nicholas C Harvey3, Cyrus Cooper3, Colin P Sibley6, Jocelyn Glazier6, Christian Wadsack1,2, Keith M Godfrey3,5,7, Gernot Desoye1, Rohan M Lewis8. 1. Department of Obstetrics and Gynaecology, Medical University of Graz, Graz, Austria. 2. BioTechMed-Graz, Graz, Austria. 3. MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, UK. 4. Core Facility Molecular Biology, Centre for Medical Research, Medical University of Graz, Graz, Austria. 5. NIHR Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, UK. 6. Maternal and Fetal Health Research Centre, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, M13 9WL, UK. 7. Faculty of Medicine, University of Southampton, Southampton, UK. 8. Faculty of Medicine, University of Southampton, Southampton, UK. Rohan.Lewis@soton.ac.uk.
Abstract
INTRODUCTION: Alkaline phosphatase is implicated in intestinal lipid transport and in the development of obesity. Placental alkaline phosphatase is localised to the microvillous plasma membrane of the placental syncytiotrophoblast at the maternal-fetal interface, but its role is unclear. We investigated the relations of placental alkaline phosphatase activity and mRNA expression with maternal body composition and offspring fat mass in humans. METHODS: Term human placentas from the UK Birthright cohort (n = 52) and the Southampton Women's Survey (SWS) (n = 95) were studied. In the Birthright cohort, alkaline phosphatase activity was measured in placental microvillous plasma membrane vesicles. In the SWS, alkaline phosphatase mRNA was measured using Nanostring. Alkaline phosphatase gene expression was compared to other lipid-related genes. RESULTS: In Birthright samples placental microvillous plasma membrane alkaline phosphatase activity was positively associated with maternal triceps skinfold thickness and BMI (β = 0.04 (95% CI: 0.01-0.06) and β = 0.02 (0.00-0.03) µmol/mg protein/min per SD, P = 0.002 and P = 0.05, respectively) after adjusting for potential confounders. In SWS samples placental alkaline phosphatase mRNA expression in term placenta was positively associated with maternal triceps skinfold (β = 0.24 (0.04, 0.44) SD/SD, P = 0.02), had no association with neonatal %fat mass (β = 0.01 (-0.20 to 0.21) SD/SD, P = 0.93) and was negatively correlated with %fat mass at ages 4 (β = -0.28 (-0.52 to -0.04) SD/SD, P = 0.02), 6-7 (β = -0.25 (-0.49 to -0.02) SD/SD, P = 0.03) years. When compared with placental expression of other genes, alkaline phosphatase expression was positively related to genes including the lysophosphatidylcholine transporter MFSD2A (major facilitator superfamily domain containing 2A, P < 0.001) and negatively related to genes including the fatty acid transport proteins 2 and 3 (P = 0.001, P < 0.001). CONCLUSIONS: Our findings suggest relationships between placental alkaline phosphatase and both maternal and childhood adiposity. The inverse relationship between placental alkaline phosphatase gene expression and childhood %fat mass suggests that placental alkaline phosphatase may help to protect the foetus from the adverse effects of maternal obesity.
INTRODUCTION: Alkaline phosphatase is implicated in intestinal lipid transport and in the development of obesity. Placental alkaline phosphatase is localised to the microvillous plasma membrane of the placental syncytiotrophoblast at the maternal-fetal interface, but its role is unclear. We investigated the relations of placental alkaline phosphatase activity and mRNA expression with maternal body composition and offspring fat mass in humans. METHODS: Term human placentas from the UK Birthright cohort (n = 52) and the Southampton Women's Survey (SWS) (n = 95) were studied. In the Birthright cohort, alkaline phosphatase activity was measured in placental microvillous plasma membrane vesicles. In the SWS, alkaline phosphatase mRNA was measured using Nanostring. Alkaline phosphatase gene expression was compared to other lipid-related genes. RESULTS: In Birthright samples placental microvillous plasma membrane alkaline phosphatase activity was positively associated with maternal triceps skinfold thickness and BMI (β = 0.04 (95% CI: 0.01-0.06) and β = 0.02 (0.00-0.03) µmol/mg protein/min per SD, P = 0.002 and P = 0.05, respectively) after adjusting for potential confounders. In SWS samples placental alkaline phosphatase mRNA expression in term placenta was positively associated with maternal triceps skinfold (β = 0.24 (0.04, 0.44) SD/SD, P = 0.02), had no association with neonatal %fat mass (β = 0.01 (-0.20 to 0.21) SD/SD, P = 0.93) and was negatively correlated with %fat mass at ages 4 (β = -0.28 (-0.52 to -0.04) SD/SD, P = 0.02), 6-7 (β = -0.25 (-0.49 to -0.02) SD/SD, P = 0.03) years. When compared with placental expression of other genes, alkaline phosphatase expression was positively related to genes including the lysophosphatidylcholine transporter MFSD2A (major facilitator superfamily domain containing 2A, P < 0.001) and negatively related to genes including the fatty acid transport proteins 2 and 3 (P = 0.001, P < 0.001). CONCLUSIONS: Our findings suggest relationships between placental alkaline phosphatase and both maternal and childhood adiposity. The inverse relationship between placental alkaline phosphatase gene expression and childhood %fat mass suggests that placental alkaline phosphatase may help to protect the foetus from the adverse effects of maternal obesity.
Authors: María T Prieto-Sánchez; María Ruiz-Palacios; José E Blanco-Carnero; Ana Pagan; Christian Hellmuth; Olaf Uhl; Wolfgang Peissner; Antonio J Ruiz-Alcaraz; Juan J Parrilla; Berthold Koletzko; Elvira Larqué Journal: Clin Nutr Date: 2016-01-29 Impact factor: 7.324
Authors: Kanakaraju Kaliannan; Sulaiman R Hamarneh; Konstantinos P Economopoulos; Sayeda Nasrin Alam; Omeed Moaven; Palak Patel; Nondita S Malo; Madhury Ray; Seyed M Abtahi; Nur Muhammad; Atri Raychowdhury; Abeba Teshager; Mussa M Rafat Mohamed; Angela K Moss; Rizwan Ahmed; Shahrad Hakimian; Sonoko Narisawa; José Luis Millán; Elizabeth Hohmann; H Shaw Warren; Atul K Bhan; Madhu S Malo; Richard A Hodin Journal: Proc Natl Acad Sci U S A Date: 2013-04-08 Impact factor: 11.205
Authors: Hazel M Inskip; Keith M Godfrey; Siân M Robinson; Catherine M Law; David J P Barker; Cyrus Cooper Journal: Int J Epidemiol Date: 2005-09-29 Impact factor: 7.196
Authors: Yutong Chen; Dylan Siriwardena; Christopher Penfold; Adam Pavlinek; Thorsten E Boroviak Journal: Development Date: 2022-07-06 Impact factor: 6.862